Navigation Links
Safety in Children's Pain Relief Products a Primary Concern
Date:7/7/2010

Massive recalls of over-the-counter (OTC) pediatric oral pain medications and new FDA reports of the shocking conditions in manufacturing plants have pediatricians and parents concerned for children's safety.

Rhinebeck, NY (Vocus) July 7, 2010 -- Since the first of the year there have been numerous recalls of infants’ and children’s over-the-counter (OTC) pharmaceutical products, for reasons ranging from contamination to harmful effects. And in May, the Food and Drug Administration (FDA) reported a voluntary recall of certain children’s OTC liquid medicines, including specific lots of infants’ and children’s Tylenol, Motrin, Zyrtec, and Benadryl products.    

Currently, many household brand-name OTC products marketed for children are under federal scrutiny for doing more harm than good. For example, products containing the active ingredients acetaminophen and ibuprofen have been recently recalled and are suspected of causing toxicity in the body and damage to vital organs, such as the kidneys and liver. Such medications are harmful to adults, let alone a child’s delicate system.

“This is an alarming fact,” says Lou Paradise, president and chief of research at Topical BioMedics, Rhinebeck, NY, formulator of the privately held company’s line of natural topical pain relief and healing products. “Children are ‘little people,’ not ‘little adults,’ he says. “Consequently ‘mini versions’ of products made for adults are not appropriate for children as these formulas may be hazardous to their health.”

OTC topical analgesic products may also contain hidden dangers, such as parabens and other preservatives, volatile oils, and other irritating chemicals that have never been tested. “Commercial topical pain relief ointments containing such harsh ingredients as Menthol, Camphor, and Capsaicin may harm a child’s delicate system and do irreparable damage,” says Paradise. “In 2007, a 17-year-old star athlete from Staten Island, NY died from Methyl Salicylate poisoning, an ingredient commonly found in OTC topical analgesic products. Clearly we must safeguard our children’s welfare when administering any pharmaceutical.”

In May of 2009, Topical BioMedics introduced Topricin Junior for children to address the safety issues and concerns of parents and doctors in the pediatric pain relief category. Recommended by pediatricians, Topricin Junior has no odor and is specially formulated without irritating and potentially harmful chemicals. Instead, the homeopathic formula provides a synergistic blend of natural medicines that properly address children’s unique pain relief needs while stimulating the body’s natural desire to heal the damage that is causing the pain. Five percent of the sales of Topricin Junior are donated to foundations for pediatric cancer care. (Please view the 3:30 minute video for more details).

Founded in 1994 and headquartered in Rhinebeck, NY, Topical BioMedics, Inc., is the research and development leader in topical regulated natural medicines for pain relief.    The company’s flagship product, Topricin Pain Relief and Healing Cream, was introduced in 1994 and is now a leading natural therapeutic brand. All Topricin products are FDA-regulated over-the-counter medicines. Doctors and pharmacists can find more information about Topricin in the 2010 edition of the Physicians’ Desk Reference (PDR). In spring 2009 the company also introduced Topricin® Foot Therapy cream for treating painful conditions specific to feet and ankles.

All Topricin homeopathic medicines work naturally, without any known side effects, drug interactions, or contraindications. Products are available in pharmacies, natural food stores, and other retailers nationwide, as well as directly from Topical BioMedics. For additional information, visit www.topricinkids.com.

# # #

Read the full story at http://www.prweb.com/releases/children/pain_relief/prweb4229164.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Pets Guardian Provides A Pet Safety System, Ensuring Pets Will Be Cared For In Case of a Personal Emergency
2. No Health and Safety Induction for Third of UK Staff
3. Southwest Florida Safety Professionals Plan an Active Season, Featuring “Safe Florida 2010” in Fort Myers on October 29
4. Miami meeting on radiation therapy targets patient safety
5. Monmouth Vans Exclusive Dealer For New Wheelchair Safety Products
6. NHLBI funds research to improve safety of red blood cell transfusions
7. ASTRO participates in FDA meeting on radiation safety
8. Video study finds risky food-safety behavior more common than thought
9. FDA should adopt risk-based approach to food safety
10. The John Theurer Cancer Center recognizes medical physics team for safety track record
11. Don't Forget Your Home During National Sun Safety Week: June 1 – 7, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Safety in Children's Pain Relief Products a Primary Concern
(Date:4/21/2017)... ... ... The Patient Advocacy Community of The Beryl Institute presented Eve DeVaro, Director, Patient ... Award in recognition of her extraordinary contributions to the field of patient advocacy ... Institute’s annual Patient Experience Conference on March 20 in Denver, Colorado. ...
(Date:4/21/2017)... Hong Kong (PRWEB) , ... April 21, 2017 , ... ... Printing (U3DP), the first 3D printing facility among higher education institutions in Hong Kong ... 3D printing, in terms of the range and quantity of facilities in Hong Kong. ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... AWARE: A Week of Addiction and Recovery Education, from April 24 to April ... preventing substance use disorders. , The mission of AWARE is to instill ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... announced an exciting new partnership with the highly regarded and well renowned Asian ... highly innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and ...
(Date:4/21/2017)... Worcestershire, UK (PRWEB) , ... April 21, 2017 ... ... Award for Enterprise in the category of International Trade, the UK’s most prestigious ... in international trade, which represents 95% of total revenues and has grown by ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
Breaking Medicine Technology: